Articles From: Portland General Electric Reports 2012 Financial Results and Initiates 2013 Earnings Guidance to Post Holdings Schedules Second Quarter Fiscal Year 2013 Conference Call


2013/2/22
Portland General Electric Company (NYSE: POR) today reported net income of $141 million, or $1.87 per diluted share, for the year ended Dec.
Sign-up for Portland General Electric Reports 2012 Financial Results and Initiates 2013 Earnings Guidance investment picks
2013/4/2
Portland General Electric Company (NYSE:POR) announced today that it will host an analyst conference call and webcast at 11 a.m. ET on Wednesday, May 1, to review its first quarter 2013 financial results.
Sign-up for Portland General Electric Schedules Earnings Release and Conference Call for Wednesday, May 1 investment picks
2013/4/12
Portola Pharmaceuticals has filed plans to raise up to $150 million through an initial public offering.
Sign-up for Portola Pharmaceuticals Files Plans for $150 Million IPO investment picks
2013/4/5
The photographer that ran the portrait studios at Wal-Mart Stores Inc. (WMT), Sears Holdings Corp.
Sign-up for Portrait Studios At Wal-Mart, Sears Are Abruptly Shuttered investment picks
2013/5/6
LISBON --The Portuguese government has hired banks for the sale of 10-year bonds, signalling it could soon issue the long-term debt for the first time since it requested a bailout in early 2011, a person familiar with the situation said Monday.
Sign-up for Portugal Hires Banks for 10-Year Bond Sale investment picks
2013/5/6
LISBON --The Portuguese government has hired banks for the sale of 10-year bonds, signalling it could soon issue the long-term debt for the first time since it requested a bailout in early 2011, a person familiar with the situation said Monday.
Sign-up for Portugal Hires Banks for 10-Year Bond Sale - Source investment picks
2013/4/22
ATHENS --
Sign-up for Portugal's BCP Bank Sells Greek Unit to Piraeus investment picks
2013/5/6
LISBON --
Sign-up for Portugal's BCP Bank Swings to E152 Million Loss investment picks
2013/5/9
LISBON --Portuguese energy company Energias de Portugal SA (EDP.LB), or EDP, Thursday said first-quarter net profit fell 1% from a year earlier, as a result of higher taxes and provisions.
Sign-up for Portugal's EDP 1Q Net Profit Down 1% on Higher Taxes investment picks
2013/2/11
A New Choice for U.S. Point-of-Sale (POS) Value-Added Resellers GARDENA, Calif.
Sign-up for POSBANK USA Announces Distribution Agreement With SYNNEX Corporation To Enhance STORESolv Solutions Offering investment picks
2013/4/25
SEOUL --
Sign-up for Posco 1Q Net Profit Plunges 54%; Lower Demand Weighs investment picks
2013/2/26
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0856242001&sourceType=1 http://www.ccnmatthews.com/logos/20111101-poseidon_logo_200.jpg CALGARY, ALBERTA --
Sign-up for Poseidon Concepts Corp. Provides Personnel Update investment picks
2013/3/28
Posera-HDX Announces Financial Results for Fiscal 2012 Canada NewsWire The Company continues to pursue acquisitions within the point of sale and payments industries although none are specifically named at this time.
Sign-up for Posera-HDX Announces Financial Results for Fiscal 2012 investment picks
2013/4/10
Posera-HDX Ltd.
Sign-up for Posera-HDX Ltd. to Acquire Payments Company Zomaron Inc. investment picks
2013/4/26
Today, Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. (Nasdaq: MDVN) have received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP), recommending European Commission (EC) approval for XTANDI ® (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.
Sign-up for POSITIVE CHMP OPINION FOR XTANDI (ENZALUTAMIDE) IN ADVANCED PROSTATE CANCER investment picks
2013/3/4
http://media.marketwire.com/attachments/201212/107982_FSE_Logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=992446&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Positive Outlook for Oil Industry in 2013 as EIA and OPEC Raise Forecasts for Global Oil Demand investment picks
2013/2/18
http://media.marketwire.com/attachments/201212/107982_FSE_Logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=986839&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Positive Outlook for Oil Industry in 2013 as EIA and OPEC Raise Forecasts for Global Oil Demand investment picks
2013/2/26
http://media.marketwire.com/attachments/201212/107982_FSE_Logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=990174&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Positive Outlook for Oil Industry in 2013 as EIA and OPEC Raise Forecasts for Global Oil Demand investment picks
2013/2/22
http://media.marketwire.com/attachments/201212/107982_FSE_Logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=989035&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Positive Outlook for Oil Industry in 2013 as EIA and OPEC Raise Forecasts for Global Oil Demand investment picks
2013/2/20
http://media.marketwire.com/attachments/201212/107982_FSE_Logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=987862&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Positive Outlook for Oil Industry in 2013 as EIA and OPEC Raise Forecasts for Global Oil Demand investment picks
2013/5/1
LEXINGTON, Mass., May 1, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) today announced that preliminary data from a Phase 2 clinical trial showed that newly diagnosed glioblastoma multiforme (GBM) patients treated with Prophage G-100 (Heat Shock Protein-Peptide Complex-96, HSPPC-96) vaccine plus the standard of care showed a 146% increase in progression free survival (PFS) and a 60% increase in overall survival (OS) as compared to the standard of care alone.
Sign-up for Positive Phase 2 Data from Agenus' Brain Cancer Vaccine Presented at Plenary Session of American Academy of Neurological Surgeons Meeting investment picks
2013/4/7
NKTR-214 Demonstrates Improved Efficacy in Resistant Preclinical Melanoma Model Through Preferential Activation of Tumor Killing Immune Cell Subtype SAN FRANCISCO , April 7, 2013 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today presented positive preclinical data for NKTR-214, a novel cancer immunotherapy which targets the IL-2 receptor complex, at the 2013 American Association for Cancer Research (AACR) Annual Meeting.
Sign-up for Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013 investment picks
2013/3/20
Today Biogen Idec (NASDAQ: BIIB) announced the positive, full first-year results from its two-year pivotal Phase 3 ADVANCE study of PLEGRIDY™ (peginterferon beta-1a), the company’s investigational candidate for relapsing-remitting multiple sclerosis (RRMS) dosed once every two weeks or every four weeks.
Sign-up for Positive Year One Results from Biogen Idec Phase 3 ADVANCE Trial of PLEGRIDY™ (Peginterferon Beta-1a) Presented at AAN Meeting investment picks
2013/4/22
DELRAY BEACH, Fla., April 22, 2013 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of biological detection and diagnostics solutions, today announced its Board of Directors has approved a reverse split of its common stock at a ratio of 1-for-25 commencing at the open of trading on April 23, 2013.
Sign-up for PositiveID Corporation Announces Reverse Stock Split investment picks
2013/2/6
DELRAY BEACH, Fla., Feb.
Sign-up for PositiveID Reports Issuance of Draft RFP From Dept of Homeland Security for BioWatch Generation 3 investment picks
2013/4/29
PossibleNOW, the leading provider of customer experience and enterprise preference management solutions, today announced that it has partnered with leading email and cross-channel marketing solutions provider Responsys, Inc. (Nasdaq:MKTG) to provide technology supporting Interact Preference, a new offering within the Responsys Interact Suite.
Sign-up for PossibleNOW Partners with Responsys on New Offering investment picks
2013/4/2
Post Properties, Inc. (NYSE: PPS) will release its first quarter earnings after the market closes on Monday, April 29, and hold its quarterly conference call on Tuesday, April 30, at 10:00 a.m. ET.
Sign-up for Post Announces Date of First Quarter 2013 Earnings Release and Conference Call investment picks
2013/3/21
ST. LOUIS, Mo.
Sign-up for Post Foods Considering Capacity Rationalization investment picks
2013/5/1
ST. LOUIS , May 1, 2013 /PRNewswire/ -- Post Holdings, Inc. (NYSE: POST) invites investors to listen to a live broadcast of the Company's conference call to discuss second quarter fiscal year 2013 financial results and discuss fiscal 2013 outlook on Monday, May 13, 2013 at 4:30 p.m. Eastern Time .
Sign-up for Post Holdings Schedules Second Quarter Fiscal Year 2013 Conference Call investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Portland General Electric Reports 2012 Financial Results and Initiates 2013 Earnings Guidance to Post Holdings Schedules Second Quarter Fiscal Year 2013 Conference Call
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity